Association between CDK4/6 inhibitors and drug-related osteonecrosis of the jaw: A pharmacoepidemiological study using the FDA Adverse Events Reporting System.

Prolia (denosumab) - Amgen

Ibrance (palbociclib) - Pfizer

Verzenio (abemaciclib) - Eli Lilly

crenolanib (ARO-002) - AROG

http://www.ncbi.nlm.nih.gov/pubmed/38619193

Eiseki Usami; Hiroki Asano; Makiko Go; Michio Kimura; Rikuto Masuda; Tomoaki Yoshimura; Yoshihiro Noguchi

Apr 15, 2024